Hepatitis Forums
Hepatitis B Main Forums => Hepatitis B => Topic started by: Hep Editors on January 05, 2017, 10:40:32 am
-
The U.S. Food and Drug Administration (FDA) has approved Vemlidy (tenofovir alafenamide, or TAF) to treat adults with chronic hepatitis B virus (HBV) who have compensated cirrhosis of the liver, Medscape reports.
Vemlidy is the brand name for a new version of the generic drug tenofovir. Viread (tenofovir disoproxil fumarate, or TDF), which is the brand name for the older version of tenofovir, is already approved to treat hep B.
For more information...
https://www.hepmag.com/article/fda-approves-vemlidy-tenofovir-alafenamide-taf-hepatitis-b